USANA Health Sciences (USNA) Misses Q4 EPS by 1c, Revenues Miss; Offers FY EPS/Revenue Guidance Above Consensus
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/13/2026
- Wall St futures tick higher as oil retreats ahead of inflation data
- Oil falls on weaker demand outlook and higher US stocks
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
- Birkenstock surges on revenue beat, higher full-year outlook
- After-Hours Movers: CSCO, COHR, HLIT, CBRS, STUB, ENS
- After-Hours Movers: CRWV, NBIS, SMCI, LITE, CAVA, HRB
- After-Hours Movers: P, RIOT, BW, RKLB, HIMS, UPWK
- After-Hours Movers: TEAM, NET, TWLO, DOCS, FROG, DV, TTD, ABNB, DKNG, SG, RKT
- After-Hours Stock Movers: WDC, SNDK, FIG, APP, HUBS, SOUN, DASH, XYZ, Z, FLNC
USANA Health Sciences Reports Record Full-Year 2018 Results
February 5, 2019 4:17 PM ESTRecord fiscal year net sales of $1.189 billion, an increase of 13.6% Record fiscal year net earnings of $126.2 million, or $5.12 per share Fourth quarter net sales of $299.0 million, an increase of 9.5% year-over-year Fourth quarter net earnings of $32.3 million, or $1.32 per share
SALT LAKE CITY--(BUSINESS WIRE)-- USANA Health Sciences, Inc. (NYSE: USNA) today announced financial results for its fiscal fourth quarter and full-year ended December 29, 2018.
Financial Performance
Fourth quarter 2018 net sales... More
